Ann: BTM delivers positive First in Man results in Cell Therapies, page-48

  1. 8,133 Posts.
    lightbulb Created with Sketch. 1411
    To counter - this is a proof of concept study and despite having low population was wildly successful.

    I think most understand this is very early days. But it's the potential of these results that is the most exciting currently.

    And I think the shorters are not relying on a potential cap raise for their exit, they were trying to push us out of the asx200 again, which is looking less likely by the day.

    Even if they're betting on a cap raise, do you think they're right? The math doesn't support that.
    Last edited by DocMcstuffins: 13/05/25
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.32
Change
0.095(7.76%)
Mkt cap ! $911.9M
Open High Low Value Volume
$1.35 $1.39 $1.26 $9.378M 7.081M

Buyers (Bids)

No. Vol. Price($)
2 3870 $1.31
 

Sellers (Offers)

Price($) Vol. No.
$1.33 6818 1
View Market Depth
Last trade - 16.13pm 30/07/2025 (20 minute delay) ?
PNV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.